Pharmabiz18m
Pfizer’s sasanlimab in combo with BCG improves EFS in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer
Pfizer’s sasanlimab in combo with BCG improves EFS in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer: New York Monday, January 13, 2025, 13:00 Hrs [IST] ...
Pharmabiz34m
Aragen secures $100 million investment from Quadria Capital
Aragen, a globally renowned contract research, development and manufacturing organization (CRDMO), announced that it has secured a $100 million investment from Quadria Capital, an Asia ...
Pharmabiz1h
AIG Group of Hospitals in Hyderabad to invest Rs. 800 crore in Proton Beam Therapy to treat complex cancers
AIG Group of Hospitals in Hyderabad to invest Rs. 800 crore in Proton Beam Therapy to treat complex cancers: Our Bureau, Chennai Monday, January 13, 2025, 12:15 Hrs [IST] The Boar ...
Pharmabiz2h
Bayer announces positive results of pivotal phase III QUANTI studies of gadoquatrane, an investigational GBCA for use in magnetic resonance imaging
Bayer announces positive results of pivotal phase III QUANTI studies of gadoquatrane, an investigational GBCA for use in magnetic resonance imaging: Berlin Monday, January 13, 202 ...
Pharmabiz5h
KPRDO asks FDA to take action against Swiggy & PharmEasy for drug delivery in 10 minutes
KPRDO asks FDA to take action against Swiggy & PharmEasy for drug delivery in 10 minutes: Nandita Vijayasimha, Bengaluru ...
Pharmabiz4h
ASPA to host 6th edition of Traceability and Authentication Forum 2025 on March 17 & 18 at New Delhi
ASPA to host 6th edition of Traceability and Authentication Forum 2025 on March 17 & 18 at New Delhi: Our Bureau, Bengaluru Monday, January 13, 2025, 09:00 Hrs [IST] The Authentic ...
Pharmabiz5h
Panel asks govt to provide duty concessions, reduced GST rates for growth of medical devices manufacturing
Panel asks govt to provide duty concessions, reduced GST rates for growth of medical devices manufacturing: Gireesh Babu, New Delhi Monday, January 13, 2025, 08:00 Hrs [IST] A Par ...
Pharmabiz5h
MP DCA forms team of regulatory officers to assist pharma units in upgrading plants as per revised Schedule M
Peethaambaran Kunnathoor, Chennai Monday, January 13, 2025, 08:00 Hrs [IST] ...
Pharmabiz5h
Allowing separate timelines for large units and MSMES may create two categories of manufacturing facilities: Experts
Gireesh Babu, New Delhi Monday, January 13, 2025, 08:00 Hrs [IST] ...
Pharmabiz5h
Exporters concerned over delay in getting relief under Section 43B(h) of IT Act
Exporters concerned over delay in getting relief under Section 43B(h) of IT Act: Shardul Nautiyal, Mumbai Monday, January 13, 2025, 08:00 Hrs [IST] India’s pharmaceutical export ...
Pharmabiz3h
New European Union rules for health technology assessments become effective
New European Union rules for health technology assessments become effective: Amsterdam, The Netherlands Monday, January 13, 2025, 10:00 Hrs [IST] EMA is ready to support the imple ...
Pharmabiz2d
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor
Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, oral therapeutics for RAS-driven cancers, announced progress across its pipeline ...